Abstract:The expanding gene‐editing toolbox has driven a biomedical revolution. These molecular tools tremendously contribute to the progression of fundamental research, such as epigenetics, drug development, disease modeling, and disease diagnosis. Furthermore, therapeutic gene editing offers a profound opportunity to improve the current treatment of human diseases. The expanding genome editing toolbox has revolutionized life science research ranging from the bench to the bedside. These "molecular scissors" have offered us unprecedented abilities to manipulate nucleic acid sequences precisely in living cells from diverse species. Continued advances in genome editing exponentially broaden our knowledge of human genetics, epigenetics, molecular biology, and pathology. Currently, gene editing‐mediated therapies have led to impressive responses in patients with hematological diseases, including sickle cell disease and thalassemia. With the discovery of more efficient, precise and sophisticated gene‐editing tools, more therapeutic gene‐editing approaches will enter the clinic to treat various diseases, such as acquired immunodeficiency sydrome (AIDS), hematologic malignancies, and even severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. These initial successes have spurred the further innovation and development of gene‐editing technology. In this review, we will introduce the architecture and mechanism of the current gene‐editing tools, including clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR‐associated nuclease‐based tools and other protein‐based DNA targeting systems, and we summarize the meaningful applications of diverse technologies in preclinical studies, focusing on the establishment of disease models and diagnostic techniques. Finally, we provide a comprehensive overview of clinical information using gene‐editing therapeutics for treating various human diseases and emphasize the opportunities and challenges.

The Bibliometric Landscape of Gene Editing Innovation and Regulation in the Worldwide

Determination of Factors Driving the Genome Editing Field in the CRISPR Era Using Bibliometrics.

Genome editing with the CRISPR-Cas system: an art, ethics and global regulatory perspective

Genome Editing with the CRISPR‐Cas System: an Art, Ethics and Global Regulatory Perspective

Current landscape of gene‐editing technology in biomedicine: Applications, advantages, challenges, and perspectives

The Development of Gene Editing Technology and Controversial Issues: A Discussion

Gene editing technology and its research progress in China

The application and development of CRISPR Cas9

Gene Editing and Its Applications in Biomedicine

Gene Editing's Sharp Edge: Understanding Zinc Finger Nucleases (ZFN), Transcription Activator-Like Effector Nucleases (TALEN) and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)

Knowledge Mapping and Current Trends of Global Research on CRISPR in the Field of Cancer

Gene editing: from technologies to applications in research and beyond

Application of Gene Editing Technology on Germplasm Resources

Research progress in gene editing technology.

Advances in the Engineering of the Gene Editing Enzymes and the Genomes: Understanding and Handling the Off-Target Effects of CRISPR/Cas9.

Genome Editing Technology and Medical Applications.

[Development and Challenges of Gene Editing Technology].

CRISPR/Cas System: Recent Advances and Future Prospects for Genome Editing

Current Status, Challenges, and Future Prospects of Plant Genome Editing in China

Human Embryo Gene Editing: God's Scalpel or Pandora's Box?

Gene editing technology: shaping international standards for health and food safety assurance